Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients

Nephrology

Volumn 12, Issue 4, 2007, Pages 331-336

  Perunicic Pekovic, Gordana B ^a   Rasic, Zorica R ^a   Pljesa, Steva I ^a   Sobajic, Sladjana S ^b   Djuricic, Ivana ^b   Maletic, Radojka ^c   Ristic Medic, Danijela K ^d  

^a University Hospital Zemun   (Serbia)

^b Faculty of Pharmacy   (Serbia)

^c Faculty of Agriculture   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

ESRD; Inflammation; Malnutrition; Phospholipid; PUFA; Red cell

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LIPID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; CELL FUNCTION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY FAILURE; LIPID BLOOD LEVEL; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; SEX RATIO;

BIOLOGICAL MARKERS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RENAL DIALYSIS;

EID: 34447545528     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00777.x     Document Type: Article

References (36)

1. Stenvinkel P. Inflammatory and atherosclerosis interactions in the depleted uremic patients. Blood Purif. 2001 19 : 53 61.
2. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999 55 : 648 58.
3. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am. J. Kidney Dis. 1998 32 : 107 14.
4. Kaizu Y, Kimura M, Yoneyama T et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am. J. Kidney Dis. 1998 31 : 93 100.
5. Stenvinkel P, Heimburger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid atherosclerosis in dialysis patients: Association with chlamydia pneumoniae seropositivity. Am. J. Kidney Dis. 2002 39 : 274 82.
6. Ross R. Atherosclerosis: An inflammatory disease. N. Engl. J. Med. 1999 340 : 115 26.
7. Ebisuri C, Tsujinaka T, Morimoto T et al. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsin B and L, proteasome) in C2C12 myotubes. Clin. Sci. 1995 89 : 431 9.
8. Tsujinaka T, Fujita J, Ebisuri C et al. Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin-6 transgenic mice. J. Clin. Invest. 1996 97 : 244 9.
9. King AJ, Kehayas JJ, Roubenhoff R et al. Cytokine production and nutritional status in hemodialysis patients. Int. J. Artif. Organs 1998 21 : 4 11.
10. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999 55 : 1899 911.
11. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991 54 : 438 63.
12. Burr ML, Fehily AM, Gilbert JF et al. Effect of change in fat, fish and fibre intakes on death and myocardial infarction: Diet and reinfarction trial (DART). Lancet 1989 2 : 757 61.
13. de Lorgeril M, Renaud S, Mamelle N et al. Mediterranean α-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994 343 : 1454 9.
14. Siscovick DS, Raghunathan TE, King I et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995 274 : 1363 7.
15. Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effect of dietary fish oil on ventricular premature complexes. Am. J. Cardiol. 1995 76 : 974 7.
16. Koorts AM, Viljoen M, Kruger MC. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot. Essent. Fatty Acids 2002 67 : 13 18.
17. Kates M. Techniques of Lipidology. Amsterdam : Elsevier Publishers Co., 1972.
18. Metcalfe LD, Schmitz AA. The rapid preparation of fatty acid esters for gas chromatographic analysis. Anal. Chem. 1961 33 : 363 4.
19. International Standard ISO 5508-1978 (E).
20. International Standard ISO 5508-1979 (E).
21. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int. 2005 67 : 1216 33.
22. Ristic V, Tepsic V, Ristic-Medic D et al. Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients. Ren. Fail. 2006 28 : 211 16.
23. Perunicic-Pekovic G, Rasic Z, Ristic V, Pljesa S, Lambic LJ, Djurkovic V. Interactions between nutritional parameters and polyunsaturated fatty acids (PUFAs) profiles in plasma phospholipids in hemodialysis patients. Cardionephrology, Editoriale Bios, Cosenza 2004 8 : 333 5.
24. Grimsgaard S, BØnaa KH, Bjerve KS. Fatty acid chain length and degree of unsaturation are inversely associated with serum triglycerides. Lipids 2000 35 : 1185 93.
25. De Gomez Dumm NT, Giammona AM, Touceda LA, Raimondi A. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina (B Aires) 2001 61 : 142 6.
26. Varga Z, Karpati I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: Relationship between fatty acids, lipid parameters, and diseases. Nephron 1997 77 : 417 21.
27. Sasagawa T, Suzuki K, Shiota T, Kondo T, Okita M. The significance of plasma lysophospholipid in patients with renal failure on hemodialysis. J. Nutr. Sci. Vitaminol. (Tokyo) 1998 44 : 809 18.
28. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Downregulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses 1999 52 : 465 77.
29. Mayer K, Schmidt R, Muhly-Reinholz M et al. In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFα impact of ω-3 versus ω-6 fatty acids. J. Lipid Res. 2002 43 : 944 51.
30. Lerner RP, Lindstróm AB, Berg A, Johansson E, Rosendahl K, Palmblad J. Development and characterization of essential fatty acid deficiency in human endothelial cells in culture. Proc. Natl. Acad. Sci. USA 1995 92 : 1147 51.
31. Hishinuma T, Yamazaki T, Mizugaki M. Effects of long-term supplementation of eicosapentaenoic acid and docosahexaenoic acid on the 2-, 3-series prostacyclin by endothelial cells. Prostaglandins Other Lipid Mediat. 1999 57 : 333 40.
32. Peck LW. Essential fatty acid deficiency in renal failure: Can supplements really help? J. Am. Diet. Assoc. 1997 97 (Suppl. 2 S150 53.
33. Sinzinger M, Leitner C. Eicosanoids of platelet and vascular wall in chronic renal insufficiency. Am. J. Nephrol. 1987 7 : 211 30.
34. Kliewer SA, Sundseth SS, Jones SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 1997 94 : 4318 23.
35. De Caterina R, Endres S, Kristensen SD, Schmidt EB. n-3 Fatty acids and renal diseases. Am. J. Kidney Dis. 1994 24 : 397 415.
36. Ghosh P, Bitsanis D, Ghebremeskel K, Crawford MA, Poston L. Abnormal aortic fatty acid composition and small artery function in offspring of rats fed a high fat diet in pregnancy. J. Physiol. 2001 533 : 822.